The position of combined medical treatment in acromegaly
Arch. endocrinol. metab. (Online)
; 63(6): 646-652, Nov.-Dec. 2019.
Artigo
em Inglês
| LILACS
| ID: biblio-1055016
Biblioteca responsável:
BR1.1
ABSTRACT
ABSTRACT Advances in combination medical treatment have offer new perspectives for acromegaly patients with persistent disease activity despite receiving the available medical monotherapies. The outcomes of combination medical treatment may reflect both additive and synergistic effects. This review focuses on combination medical treatment and its current position in acromegaly, based on clinical studies evaluating the efficacy and safety of combined medical treatment(s) and our own experiences with combination therapy. Arch Endocrinol Metab. 2019;63(6)646-52
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
LILACS
Assunto principal:
Somatostatina
/
Receptores de Somatostatina
/
Agonistas de Dopamina
/
Hormônio do Crescimento Humano
Aspecto:
Preferência do paciente
Limite:
Humanos
Idioma:
Inglês
Revista:
Arch. endocrinol. metab. (Online)
Assunto da revista:
Endocrinologia
/
Metabolismo
Ano de publicação:
2019
Tipo de documento:
Artigo
País de afiliação:
Hungria
Instituição/País de afiliação:
Erasmus University Medical Center Rotterdam/hungria